相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increasing complexity of NLRP3 inflammasome regulation
Julien Moretti et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2021)
The post-COVID syndrome: How deep is the damage?
Prerna Garg et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19
Jean-Louis Gueant et al.
ALLERGY (2021)
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
Tamara S. Rodrigues et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Genetic mechanisms of critical illness in COVID-19
Erola Pairo-Castineira et al.
NATURE (2021)
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Kris M. White et al.
SCIENCE (2021)
Coronavirus Infections-More Than Just the Common Cold
Catharine I. Paules et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
Guadalupe Garcia-Tsao et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Covid-19-Navigating the Uncharted
Anthony S. Fauci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Morphological anomalies of circulating blood cells in COVID-19
Gina Zini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux et al.
AUTOIMMUNITY REVIEWS (2020)
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
Jaume Alijotas-Reig et al.
AUTOIMMUNITY REVIEWS (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Zhou et al.
CELL HOST & MICROBE (2020)
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2020)
Management of COVID-19 Respiratory Distress
John J. Marini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 update: Covid-19-associated coagulopathy
Richard C. Becker
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: targeting a potential IL-1β/Neutrophil Extracellular Traps feedback loop
Ahmed Yaqinuddin et al.
MEDICAL HYPOTHESES (2020)
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
Joseph T. Wu et al.
NATURE MEDICINE (2020)
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
Ashley Barlow et al.
PHARMACOTHERAPY (2020)
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort
Marie Pouletty et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Hanny Al-Samkari et al.
BLOOD (2020)
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
Raul D. Mitrani et al.
HEART RHYTHM (2020)
Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes
Corlia Grobler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City
Eva W. Cheung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Persistent Symptoms in Patients After Acute COVID-19
Angelo Carfi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
Bhawna Tomar et al.
CELLS (2020)
Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19
Alexander Kroemer et al.
JOURNAL OF HEPATOLOGY (2020)
Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19
Jeremy K. Y. Yap et al.
JOURNAL OF IMMUNOLOGY (2020)
Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2
Davinder Singh-Grewal et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2020)
Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
Jason Kim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques
Malika Aid et al.
CELL (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection
Brody H. Foy et al.
JAMA NETWORK OPEN (2020)
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study
Bernadette Schurink et al.
LANCET MICROBE (2020)
COVID-19 and multisystem inflammatory syndrome in children and adolescents
Li Jiang et al.
LANCET INFECTIOUS DISEASES (2020)
Coronaviruses and SARS-COV-2
Mustafa Hasoksuz et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo
Catherine T. Frenette et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Role of pyroptosis in cardiovascular diseases
Chang Jia et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Caspase-8 restricts antiviral CD8 T cell hyperaccumulation
Yanjun Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2019)
Recent Advances in the Molecular Mechanisms Underlying Pyroptosis in Sepsis
Yu-Lei Gao et al.
MEDIATORS OF INFLAMMATION (2018)
Plasma membrane changes during programmed cell deaths
Yingying Zhang et al.
CELL RESEARCH (2018)
The Effects of Obesity on CD47 Expression in Erythrocytes
Maciej Wiewiora et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2017)
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
Si Ming Man et al.
IMMUNOLOGICAL REVIEWS (2017)
Gasdermins: Effectors of Pyroptosis
Stephen B. Kovacs et al.
TRENDS IN CELL BIOLOGY (2017)
Interferons and inflammasomes: Cooperation and counterregulation in disease
Larisa I. Labzin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
Mubeccel Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
Khurrum Shahzad et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Yuan He et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Protein kinase C mediates caspase 3 activation: A role for erythrocyte morphology changes
Cristiana Carelli-Alinovi et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Mechanism of NLRP3 inflammasome activation
Fayyaz S. Sutterwala et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA
Anthony Rongvaux et al.
CELL (2014)
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Gilad Doitsh et al.
NATURE (2014)
Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients
Emilia Maellaro et al.
ACTA DIABETOLOGICA (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Increased Caspase-3 Immunoreactivity of Erythrocytes in STZ Diabetic Rats
Ugur Firat et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
IL-1, IL-18, and IL-33 families of cytokines
William P. Arend et al.
IMMUNOLOGICAL REVIEWS (2008)
First-in-class pan caspase inhibitor developed for the treatment of liver disease
SD Linton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
IL-converting enzyme/caspase-I inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients
JH Stack et al.
JOURNAL OF IMMUNOLOGY (2005)
Functional consequences of caspase activation in cardiac myocytes
C Communal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
分享论文
